These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 23264241

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adipocytokines and blood pressure, lipids and glucose metabolism in hypertensive perimenopausal women.
    Olszanecka A, Pośnik-Urbańska A, Kawecka-Jaszcz K, Czarnecka D, Fedak D.
    Kardiol Pol; 2010 Jul; 68(7):753-60. PubMed ID: 20648430
    [Abstract] [Full Text] [Related]

  • 3. Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis.
    Kontunen P, Vuolteenaho K, Nieminen R, Lehtimäki L, Kautiainen H, Kesäniemi Y, Ukkola O, Kauppi M, Hakala M, Moilanen E.
    Scand J Rheumatol; 2011 Jul; 40(4):256-62. PubMed ID: 21453187
    [Abstract] [Full Text] [Related]

  • 4. Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension.
    Papadopoulos DP, Makris TK, Perrea D, Papazachou O, Daskalaki M, Sanidas E, Votteas V.
    Blood Press; 2008 Jul; 17(1):50-4. PubMed ID: 18568692
    [Abstract] [Full Text] [Related]

  • 5. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
    Hong SC, Yoo SW, Cho GJ, Kim T, Hur JY, Park YK, Lee KW, Kim SH.
    Menopause; 2007 Jul; 14(5):835-40. PubMed ID: 17667144
    [Abstract] [Full Text] [Related]

  • 6. Relationship between serum adipocytokine levels and metabolic syndrome in menopausal women.
    Park HT, Cho SH, Cho GJ, Shin JH, Hong SC, Kim T, Hur JY, Kim YT, Kim SH.
    Gynecol Endocrinol; 2009 Jan; 25(1):27-31. PubMed ID: 19165660
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [Abstract] [Full Text] [Related]

  • 8. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
    Krawczyk K, Szczesniak P, Kumor A, Jasinska A, Omulecka A, Pietruczuk M, Orszulak-Michalak D, Sporny S, Malecka-Panas E.
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
    [Abstract] [Full Text] [Related]

  • 9. Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence.
    Cizmecioglu FM, Etiler N, Ergen A, Gormus U, Keser A, Hekim N, Hamzaoglu O, Hatun S.
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):622-7. PubMed ID: 19235133
    [Abstract] [Full Text] [Related]

  • 10. [Association between adipokines and the development of osteopenic syndrome in end-stage lung disease].
    Kochetkova EA, Ugaĭ LG, Buria KA, Nevzorova VA, Massard J.
    Ter Arkh; 2012 Nov; 84(12):40-4. PubMed ID: 23479987
    [Abstract] [Full Text] [Related]

  • 11. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D, Chalikias G, Parissis JT, Hatzinikolaou H, Stakos D, Papadopoulou E, Kortsaris A, Hatseras D.
    Eur Cytokine Netw; 2004 Nov; 15(3):231-9. PubMed ID: 15542448
    [Abstract] [Full Text] [Related]

  • 12. High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels.
    da Silva TF, Levy-Neto M, Bonfá E, Pereira RM.
    J Rheumatol; 2013 Nov; 40(11):1897-904. PubMed ID: 24037555
    [Abstract] [Full Text] [Related]

  • 13. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.
    Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C.
    Obes Res; 2004 Jun; 12(6):962-71. PubMed ID: 15229336
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL, Kosmiski LA, Zineh I, Rome LC, Knutsen SD.
    Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
    [Abstract] [Full Text] [Related]

  • 15. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women.
    Ding QF, Hayashi T, Zhang XJ, Funami J, Ge L, Li J, Huang XL, Cao L, Zhang J, Akihisa I.
    J Diabetes Complications; 2007 Mar; 21(5):315-9. PubMed ID: 17825756
    [Abstract] [Full Text] [Related]

  • 16. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus.
    Santos FM, Telles RW, Lanna CC, Teixeira AL, Miranda AS, Rocha NP, Ribeiro AL.
    Lupus; 2017 Jan; 26(1):10-16. PubMed ID: 27365371
    [Abstract] [Full Text] [Related]

  • 17. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
    Safranow K, Dziedziejko V, Rzeuski R, Czyzycka E, Wojtarowicz A, Bińczak-Kuleta A, Jakubowska K, Olszewska M, Ciechanowicz A, Kornacewicz-Jach Z, Machaliński B, Pawlik A, Chlubek D.
    Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
    [Abstract] [Full Text] [Related]

  • 18. Effect of red wine on adipocytokine expression and vascular alterations in fructose-fed rats.
    Vazquez-Prieto MA, Renna NF, Diez ER, Cacciamani V, Lembo C, Miatello RM.
    Am J Hypertens; 2011 Feb; 24(2):234-40. PubMed ID: 20885371
    [Abstract] [Full Text] [Related]

  • 19. Association of free fatty acids (FFA) and tumor necrosis factor-alpha (TNF-alpha) and insulin-resistant metabolic disorder.
    Ohmura E, Hosaka D, Yazawa M, Tsuchida A, Tokunaga M, Ishida H, Minagawa S, Matsuda A, Imai Y, Kawazu S, Sato T.
    Horm Metab Res; 2007 Mar; 39(3):212-7. PubMed ID: 17373637
    [Abstract] [Full Text] [Related]

  • 20. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity.
    Bogdanski P, Suliburska J, Grabanska K, Musialik K, Cieslewicz A, Skoluda A, Jablecka A.
    Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):816-23. PubMed ID: 22913215
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.